Latest News
-
Peptide to treat MND
A peptide given as a nasal spray might treat motor neurone disease, British scientists have suggested. Read more
-
Move opioid patients to alternative therapies – guidance
A drive to reduce opioid prescriptions in primary care is having success as patients move to therapeutic alternatives to drugs, it was announced today. Read more
-
20-year epigenetics mystery solved
A 20-year mystery of how epigenetic modifications act as traffic lights to control gene expression has finally been uncovered, British scientists have announced. Read more
-
Health boost from brief physical activity
One in ten premature deaths could be avoided if everyone achieved just half the recommended level of physical activity, researchers say today. Read more
-
Vaccine may improve long COVID symptoms
Vaccination may reduce the severity and impact of long COVID symptoms, researchers report today. Read more
-
Injury risk higher for e-scooters than bicycles
Users of e-scooters face a significantly greater risk of serious injury than cyclists, according to an analysis published today. Read more
-
Dystrophin link to cancer
The dystrophin gene may have a role in cancer, British researchers have reported. Read more
-
Head injury a ‘risk factor for developing brain cancer’
A mechanism that explains how head injury could be a risk factor for a rare brain tumour has been revealed by British researchers. Read more
-
Promising early gene therapy trial for ‘childhood dementia’
An investigational gene therapy for a syndrome that leads to a form of childhood dementia has shown promising early results in a proof-of-concept study, a conference will hear today. Read more
-
Urban hayfever symptoms ‘worse than rural areas’
People living in urban areas have worse hay fever symptoms than those living in rural areas of the country, according to the first study of its kind. Read more